RT Journal Article
SR Electronic
T1 Understanding Psychiatric Illness Through Natural Language Processing (UNDERPIN): Rationale, Design, and Methodology
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.12.05.21267037
DO 10.1101/2021.12.05.21267037
A1 Kishimoto, Taishiro
A1 Nakamura, Hironobu
A1 Kano, Yoshinobu
A1 Eguchi, Yoko
A1 Kitazawa, Momoko
A1 Liang, Kuo-ching
A1 Kudo, Koki
A1 Sento, Ayako
A1 Takamiya, Akihiro
A1 Horigome, Toshiro
A1 Yamasaki, Toshihiko
A1 Sunami, Yuki
A1 Kikuchi, Toshiaki
A1 Nakajima, Kazuki
A1 Tomita, Masayuki
A1 Bun, Shogyoku
A1 Momota, Yuki
A1 Sawada, Kyosuke
A1 Murakami, Junichi
A1 Takahashi, Hidehiko
A1 Mimura, Masaru
A1 on behalf of the UNDERPIN Collaborators
YR 2021
UL http://medrxiv.org/content/early/2021/12/07/2021.12.05.21267037.abstract
AB Introduction Psychiatric disorders are diagnosed according to diagnostic criteria such as the DSM-5 and ICD-11. Basically, psychiatrists extract symptoms and make a diagnosis by conversing with patients. However, such processes often lack objectivity. In contrast, specific linguistic features can be observed in some psychiatric disorders, such as a loosening of associations in schizophrenia. The purposes of the present study are to quantify the language features of psychiatric disorders and neurocognitive disorders using natural language processing and to identify features that differentiate disorders from one another and from healthy subjects.Methods This study will have a multi-center prospective design. Major depressive disorder, bipolar disorder, schizophrenia, anxiety disorder including obsessive compulsive disorder and, major and minor neurocognitive disorders, as well as healthy subjects will be recruited. A psychiatrist or psychologist will conduct 30-to-60-min interviews with each participant and these interviews will be recorded using a microphone headset. In addition, the severity of disorders will be assessed using clinical rating scales. Data will be collected from each participant at least twice during the study period and up to a maximum of five times.Discussion The overall goal of this proposed study, the Understanding Psychiatric Illness Through Natural Language Processing (UNDERPIN), is to develop objective and easy-to-use biomarkers for diagnosing and assessing the severity of each psychiatric disorder using natural language processing. As of August 2021, we have collected a total of >900 datasets from >350 participants. To the best of our knowledge, this data sample is one of the largest in this field.Trial registration UMIN000032141, University Hospital Medical Information Network (UMIN).Competing Interest StatementT. Kishimoto has received consultant fees from FRONTEO. Yoko Eguchi has received speaker's honoraria from Eisai. TH received speaker's honoraria from Yoishi-tomi. T. Kikuchi has received speaker's honoraria from Astellas, Dai-nippon Sumitomo, Eli Lilly, Janssen, MSD, Otsuka, Yoshitomi Yakuhin, Pfizer, and Takeda. JM has received speaker's honoraria from Eli Lilly, Janssen, Otsuka, MSD, Shionogi, and Pfizer. MM has received speaker's honoraria from Daiichi Sankyo, Dainippon-Sumitomo Pharma, Eisai, Eli Lilly, Fuji Film RI Pharma, Janssen Pharmaceutical, Mochida Pharmaceutical, MSD, Nippon Chemipher, Novartis Pharma, Ono Yakuhin, Otsuka Pharmaceutical, Pfizer, Takeda Yakuhin, Tsumura, and Yoshitomi Yakuhin. Also he received grants from Daiichi Sankyo, Eisai, Pfizer, Shionogi, Takeda, Tanabe Mitsubishi, and Tsumura. Other authors have no conflict of interest.Funding StatementThis research is supported by the Japan Science and Technology Agency CREST under Grant Number JPMJCR1684 and JPMJCR19F4. A former grant was awarded in 2016 and ended in 2018. A latter grant was awarded in 2019 and will end in 2021. The funding source did not participate in the design of this study and will not be involved in the study's execution, analyses, or submission of results.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Institutional Review Board of Keio University School of Medicine and the participating medical facilities.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData not available due to ethical restrictionsUNDERPINUnderstanding Psychiatric Illness Through Natural Language ProcessingDSM-5Diagnostic and Statistical Manual of Mental Disorders, Fifth EditionICD-11International Classification of Diseases 11th RevisionUMINUniversity Hospital Medical Information NetworkM.I.N.I.Mini-International Neuropsychiatric InterviewMMSEMini-Mental State Examination Mini-International; Neuropsychiatric InterviewQOLQuality Of LifeYLDsyears lived with disabilityCGI-SClinical General Impression Scale-SeveritySCIDStructural Clinical Interview for DSM-5HAM-DHamilton Depression Rating ScaleMADRSMontgomery Asberg Depression Rating ScaleYMRSYoung Mania Rating ScaleSTAIState-Trait Anxiety InventoryPANSSPositive And Negative Syndrome ScaleMMSEMini-Mental State ExaminationMoCA-JMontreal Cognitive Assessment-Japanese versionWMS-RLMWechsler Memory Scale-Revised Logical MemoryCDRClinical Dementia RatingF0fundamental FrequencyF11st formant FrequencyF22nd formant FrequencyF33rd formant FrequencyCPPCepstral Peak ProminenceMFCCMel-Frequency Cepstrum CoefficientsSVMsupport vector machinesDUPduration of untreated psychosis